ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,907Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 1187

$970K Total Retail Price of All Prescriptions

Rank: 31 out of 1187

485 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 485 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 485 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 10,523 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
METFORMIN HCL 580 355 1 7
SIMVASTATIN 527 376 2 1
OMEPRAZOLE 519 353 3 5
NAMENDA 503 447 4 44
AMLODIPINE BESYLATE 412 281 5 2
FUROSEMIDE 412 271 5 8
ALENDRONATE SODIUM 375 335 7 25
METOPROLOL TARTRATE 329 246 8 10
ZOLPIDEM TARTRATE 311 174 9 14
ENDOCET 307 89 S2 10 78
MELOXICAM 282 204 11 49
LISINOPRIL 252 131 12 4
HYDROCODONE-ACETAMINOPHEN 237 156 S3 13 20
CLOTRIMAZOLE-BETAMETHASONE 227 164 14 100
PROAIR HFA 225 106 15 41
LEVOTHYROXINE SODIUM 224 158 16 3
IBUPROFEN 220 88 17 59
CLOPIDOGREL 219 179 18 33
LISINOPRIL-HYDROCHLOROTHIAZIDE 219 127 18 39
TAMSULOSIN HCL 212 168 20 29
FLUTICASONE PROPIONATE 191 112 21 31
GLIMEPIRIDE 176 102 22 30
NEXIUM 174 142 23 15
LOVAZA 168 114 24 53
JANUVIA 166 89 25 34
SERTRALINE HCL 162 104 26 22
HYDROCORTISONE 160 106 27 217
LOSARTAN-HYDROCHLOROTHIAZIDE 157 95 28 56
DONEPEZIL HCL 155 144 29 26
OXYCODONE HCL 153 13 S2 30 38
HYDROCHLOROTHIAZIDE 148 108 31 9
OXYCODONE-ACETAMINOPHEN 140 90 S2 32 47
ATORVASTATIN CALCIUM 138 116 33 6
POLYETHYLENE GLYCOL 3350 124 93 34 86
PLAVIX 122 108 35 52
ACTOS 120 105 36 101
NIFEDIPINE ER 118 27 37 141
GABAPENTIN 114 75 38 23
CRESTOR 110 87 39 16
METOPROLOL SUCCINATE 108 88 40 11
FAMOTIDINE 105 87 41 48
GLYBURIDE 100 73 R 42 90
ENALAPRIL MALEATE 99 68 43 27
CIPROFLOXACIN HCL 99 72 43 84
NAPROXEN 94 55 45 72
ACTONEL 93 79 46 210
MECLIZINE HCL 91 76 47 112
LANTUS 87 49 48 77
PANTOPRAZOLE SODIUM 86 65 49 42
DIOVAN HCT 85 61 50 40
AZITHROMYCIN 83 56 51 24
CYMBALTA 78 64 52 60
WARFARIN SODIUM 76 37 53 13
LOSARTAN POTASSIUM 73 53 54 21
LIDODERM 72 43 55 80
PREDNISONE 71 44 56 61
TRAMADOL HCL 70 40 57 28
CEFDINIR 68 45 58 355
PROCTOZONE-HC 66 57 59 311
BYSTOLIC 62 35 60 116
ADVAIR DISKUS 61 29 61 35
PRAMIPEXOLE DIHYDROCHLORIDE 60 53 62 220
BENICAR HCT 59 33 63 170
VOLTAREN 59 43 63 126
CYCLOBENZAPRINE HCL 58 0 R 65 87
MEGACE ES 57 55 R 66 240
ACETAMINOPHEN-CODEINE 57 31 S3 66 105
POTASSIUM CHLORIDE 56 42 68 32
LEVOFLOXACIN 56 41 68 74
LANTUS SOLOSTAR 56 39 68 92
CLINDAMYCIN PHOSPHATE 54 13 71 388
HYDROXYZINE PAMOATE 52 39 R 72 398
ACYCLOVIR 52 33 72 398
RAMIPRIL 51 44 74 36
AMOXICILLIN 50 36 75 97
VESICARE 50 38 75 176
CLONIDINE HCL 50 30 75 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.